LDHA and lip and oral cavity carcinoma: Niclosamide inhibits cisplatin-induced oral cancer stem cell enrichment, increases apoptosis, limits the colony-forming potential and enhances the sensitivity of the ALDH+ OSCC cells to cisplatin